{"protocolSection":{"identificationModule":{"nctId":"NCT05996198","orgStudyIdInfo":{"id":"23-00842"},"organization":{"fullName":"NYU Langone Health","class":"OTHER"},"briefTitle":"Exoskeletal Support in Stroke","officialTitle":"A Pilot Proof of Concept, Single Site Study to Assess the Effect of Exoskeletal Support on Motor Control Strategies in Individuals With Stroke"},"statusModule":{"statusVerifiedDate":"2024-01","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-06-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-06-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-08-09","studyFirstSubmitQcDate":"2023-08-09","studyFirstPostDateStruct":{"date":"2023-08-18","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-01-04","lastUpdatePostDateStruct":{"date":"2024-01-05","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"NYU Langone Health","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true,"isUsExport":false},"descriptionModule":{"briefSummary":"This interventional study will measure motor performance, including 3D movement analysis and muscle activity, in response to exoskeleton assistance. The cohort design will compare stroke patients to healthy controls. Data collection will be conducted in a single, 2-hour session. Investigators will also access stroke patients' brain MRIs that were obtained as standard of care during acute admission for stroke."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":24,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Patients with History of Stroke","type":"EXPERIMENTAL","description":"Individuals with history of stroke more than 6 months prior to enrollment.\n\nParticipants will complete 3 blocks of 54 trials in a single session. Block 1 is a baseline phase where subjects will perform reaches without any loads applied via the exoskeleton devices. Block 2 is the intervention block where bilateral exoskeletons apply gravity assistance to the impaired arm for stroke survivors and gravity resistance to the non-impaired arm. Block 3 is a retention block, where tested procedures are identical to block 1.","interventionNames":["Device: Oculus Rift headset","Device: Exoskeleton Device"]},{"label":"Healthy Controls","type":"EXPERIMENTAL","description":"Healthy age and gender-matched control participants.\n\nParticipants will complete 3 blocks of 54 trials in a single session. Block 1 is a baseline phase where subjects will perform reaches without any loads applied via the exoskeleton devices. Block 2 is the intervention block where bilateral exoskeletons apply gravity assistance to the non-dominant arm and resistance is applied to the dominant arm in healthy controls. Block 3 is a retention block, where tested procedures are identical to block 1.","interventionNames":["Device: Oculus Rift headset","Device: Exoskeleton Device"]}],"interventions":[{"type":"DEVICE","name":"Oculus Rift headset","description":"The Oculus Rift is a commercially-available virtual reality (VR) headset. It is used to present the visual environment in which participants perform the reaching task.","armGroupLabels":["Healthy Controls","Patients with History of Stroke"]},{"type":"DEVICE","name":"Exoskeleton Device","description":"The exoskeleton was designed and constructed to provide either gravity assistance or gravity resistance. It applies a torque to both shoulders. Torque values do not exceed 50% of the torque due to gravity. The device is mounted to a testing chair and attached to the participant using Velcro straps.","armGroupLabels":["Healthy Controls","Patients with History of Stroke"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in Relative Contribution (RC) Level","description":"Measured via arm trajectory analysis as a percentage (%); evaluates arm control.","timeFrame":"Baseline, End of VR Task (Day 1 - session lasts approx. 2 hours)"},{"measure":"Change in Muscle Contribution (MC) Level","description":"Measured via electromyographical analysis as a percentage (%); evaluates arm control.","timeFrame":"Baseline, End of VR Task (Day 1 - session lasts approx. 2 hours)"}],"secondaryOutcomes":[{"measure":"Corticospinal Tract (CST) Lesion Load","description":"Measured via MRI; lesion load is expressed as percentage of the entire CST.","timeFrame":"Baseline"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nHealthy controls:\n\n* Having obtained the age of 18 years\n* Neurologically healthy (i.e., no history of: traumatic brain injury, peripheral neuropathy, seizures, etc.)\n* Strongly right-handed according to at least 80% score on the Edinburgh Handedness Inventory (Oldfield, 1971; Veale, 2013). The use of right-handed participants is a common feature in this field of study. This is due to the slight differences in arm control between left- and right-handed individuals (Sainburg \\& Kalakanis, 2000).\n* Ability to give informed consent\n\nSurvivors of stroke:\n\n* Having obtained the age of 18 years\n* have a diagnosis of stroke more than six months prior to entry into the study;\n* have the ability to reach, unsupported, to approximately 70% of arm length\n* ability to give informed consent\n\nExclusion Criteria:\n\nAll participants\n\n* have any conditions that limit their capability of using a Head Mounted Display (HMD) for a VR environment or cooperate with the protocol.\n* have any orthopedic injuries to the upper extremities.\n* Have neurological injuries other than stroke.\n* Have excessive pain in any joint of either arm that could limit the ability to cooperate with the protocols.\n* Visuospatial neglect\n* Apraxia\n* Global inattention\n* Legal blindness","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Alexander Brunfeldt, PhD","role":"CONTACT","phone":"929-455-5517","email":"alexander.brunfeldt@nyulangone.org"},{"name":"Heidi Schambra, MD","role":"CONTACT","phone":"212-598-6000","email":"Heidi.Schambra@nyulangone.org"}],"overallOfficials":[{"name":"Heidi Schambra, MD","affiliation":"NYU Langone Health","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"NYU Langone Health (222 East 41st Street)","status":"RECRUITING","city":"New York","state":"New York","zip":"10017","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: Alexander Brunfeldt, PhD \\[alexander.brunfeldt@nyulangone.org\\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.","infoTypes":["STUDY_PROTOCOL","SAP"],"timeFrame":"Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.","accessCriteria":"The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Alexander Brunfeldt, PhD \\[alexander.brunfeldt@nyulangone.org\\]. To gain access, data requestors will need to sign a data access agreement."}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}